(R)-2-amino-1-morpholino-2-phenylethan-1-one | 1307135-65-4

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 英文名称: (R)-2-amino-1-morpholino-2-phenylethan-1-one
• 英文别名: (R)-2-amino-1-morpholino-2-phenylethanone；(2R)-2-amino-1-morpholin-4-yl-2-phenylethanone
• CAS: 1307135-65-4
• 化学式: C₁₂H₁₆N₂O₂
• 分子量: 220.271
• InChiKey: GNVKZAJTOADBGR-LLVKDONJSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.1
• 重原子数：
  16
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.42
• 拓扑面积：
  55.6
• 氢给体数：
  1
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  (R)-2-amino-1-morpholino-2-phenylethan-1-one 、 2-(3,5-双-三氟甲基-苯基)- 2-甲基-丙酸 在 N,N-二异丙基乙胺 、 3-(二乙氧基邻酰氧基)-1,2,3-苯并三嗪-4-酮 作用下， 以 二氯甲烷 为溶剂， 反应 20.0h， 以0.32 g的产率得到(R)-2-(3,5-bis-trifluoromethylphenyl)-N-(2-morpholin-4-yl-2-oxo-1-phenylethyl)-isobutyramide
  参考文献：
  名称：

  Design and synthesis of potential dual NK1/NK3 receptor antagonists

  摘要：

  The tachykinin NK1 and NK3 receptors are a novel drug target for schizophrenia in order to treat not only the positive and cognitive symptoms, but also the associated co-morbid depression and sleep disturbances associated with the disease. A novel class of peptidomimetic derivatives based on a versatile phenylglycine central core was synthesized and tested in vitro as dual NK1/NK3 receptor antagonists. From this series emerged compounds with good NK1 receptor affinity, although only modest dual NK1/NK3 receptor affinity was observed with one of these analogs. (C) 2013 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2013.12.033
• 作为产物：
  描述：

  (R)-(2-morpholin-4-yl-2-oxo-1-phenyl-ethyl)-carbamic acid benzyl ester 在 10 wt% Pd(OH)2 on carbon 、 氢气 作用下， 以 甲醇 为溶剂， 反应 14.0h， 生成 (R)-2-amino-1-morpholino-2-phenylethan-1-one
  参考文献：
  名称：

  Design and synthesis of potential dual NK1/NK3 receptor antagonists

  摘要：

  The tachykinin NK1 and NK3 receptors are a novel drug target for schizophrenia in order to treat not only the positive and cognitive symptoms, but also the associated co-morbid depression and sleep disturbances associated with the disease. A novel class of peptidomimetic derivatives based on a versatile phenylglycine central core was synthesized and tested in vitro as dual NK1/NK3 receptor antagonists. From this series emerged compounds with good NK1 receptor affinity, although only modest dual NK1/NK3 receptor affinity was observed with one of these analogs. (C) 2013 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2013.12.033

文献信息

• Highly Enantioselective Synthesis of N‐Unprotected Unnatural α‐Amino Acid Derivatives by Ruthenium‐Catalyzed Direct Asymmetric Reductive Amination
  作者：Le'an Hu、Yuan‐Zheng Wang、Lei Xu、Qin Yin、Xumu Zhang

  DOI：10.1002/anie.202202552

  日期：2022.6.20

  An unprecedented Ru-catalyzed direct asymmetric reductive amination of α-keto amides with ammonium salts has been achieved. This protocol provides an efficient and practical way for the synthesis of diverse enantioenriched α-aryl- or alkyl-substituted N-unprotected unnatural α-amino acids and N-unprotected β-branched α-amino acids. Further follow-up transformations enable access to drug intermediates

  已经实现了前所未有的Ru催化的α-酮酰胺与铵盐的直接不对称还原胺化。该协议为合成多种对映体丰富的α-芳基或烷基取代的 N-未保护的非天然 α-氨基酸和 N-未保护的 β-支链 α-氨基酸提供了一种有效且实用的方法。进一步的后续转化能够获得药物中间体、肽和有机催化剂/配体。
• Design and synthesis of potential dual NK1/NK3 receptor antagonists
  作者：Stephen Hanessian、Vincent Babonneau、Nicolas Boyer、Clotilde Mannoury la Cour、Mark J. Millan、Guillaume De Nanteuil

  DOI：10.1016/j.bmcl.2013.12.033

  日期：2014.1

  The tachykinin NK1 and NK3 receptors are a novel drug target for schizophrenia in order to treat not only the positive and cognitive symptoms, but also the associated co-morbid depression and sleep disturbances associated with the disease. A novel class of peptidomimetic derivatives based on a versatile phenylglycine central core was synthesized and tested in vitro as dual NK1/NK3 receptor antagonists. From this series emerged compounds with good NK1 receptor affinity, although only modest dual NK1/NK3 receptor affinity was observed with one of these analogs. (C) 2013 Elsevier Ltd. All rights reserved.